FDA Adverse Event Malfunction Summary report: N

BIPAP AUTOSV ADV

MDR report key: 14337195 · Received May 9, 2022

Report

Report Number
2518422-2022-18188
Event Type
Malfunction
Date Received
May 9, 2022
Date of Event
April 20, 2022
Report Date
July 30, 2024
Manufacturer
RESPORINOC INC
Product Code
MNS
UDI-DI
00606959012523
PMA / PMN Number
K090539
Removal / Correction Number
RES 88058
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE MANUFACTURER PREVIOUSLY SUBMITTED MDR 2518422-2022-18188-1 .

Additional Manufacturer Narrative · 0

THE MANUFACTURER PREVIOUSLY REPORTED AN ALLEGATION OF AN ISSUE RELATED TO SOUND ABATEMENT FOAM. ADDITIONAL INFORMATION WAS RECEIVED AND SECTION B5 SHOULD BE REPORTED AS: THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUNDABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER RECEIVED INFORMATION ALLEGING AN ISSUE RELATED TO A BIPAP DEVICE'S SOUND ABATEMENT FOAM. THE PATIENT ALLEGED BEING DIAGNOSED WITH BLADDER CANCER WHILE USING THE DEVICE. THERE WAS NO MEDICAL INTERVENTION REQUIRED BY THE PATIENT. THIS NOTIFICATION WAS REVIEWED BY THE PMS CLINICAL EXPERT DUE TO THE PATIENT REPORTING BLADDER CANCER. THERE WAS NO EVIDENCE SUPPORTING THAT THE DEVICE CAUSED OR CONTRIBUTED TO THE ABOVE-MENTIONED SERIOUS INJURY. SMOKING IS A PRIMARY RISK FACTOR FOR A DIAGNOSIS OF BLADDER CANCER. THE DEVICE HAS NOT YET RETURNED TO THE MANUFACTURER FOR EVALUATION. AT THIS TIME, NO FURTHER INVESTIGATION CAN BE PERFORMED. IF ANY ADDITIONAL INFORMATION IS RECEIVED, A FOLLOW UP REPORT WILL BE FILED. SECTION(S) B1, B2, HAS CHANGED RELATED TO THE COMPLAINT CHANGING FROM THE REPORTED ADVERSE EVENT TO A PRODUCT PROBLEM. SECTION H1 HAS CHANGED TO REFLECT A MALFUNCTION. SECTION H6 HEALTH EFFECT- IMPACT CODE, TYPE OF INVESTIGATION FINDINGS AND INVESTIGATION CONCLUSIONS HAS BEEN UPDATED.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION WAS RECEIVED ON OCT 09, 2023, AND SECTION H11 SHOULD BE REPORTED AS: THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUND ABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER PREVIOUSLY RECEIVED INFORMATION ALLEGING ISSUE RELATED TO A BIPAP DEVICE'S SOUND ABATEMENT FOAM. THE PATIENT ALLEGED BEING DIAGNOSED WITH BLADDER CANCER WHILE USING THE DEVICE. ADDITIONAL INFORMATION WAS RECEIVED ALLEGATION OF DIZZINESS AND/OR HEADACHE. THERE WAS NO REPORT OF SERIOUS PATIENT HARM OR INJURY. SECTION B1 WAS CORRECTED TO PRODUCT PROBLEM. SECTION H1 WAS CHANGED FROM SERIOUS INJURY TO MALFUNCTION. SECTION H6 HEALTH EFFECTS - CLINICAL CODES AND HEALTH EFFECTS - IMPACT CODE WERE CORRECTED.

Description of Event or Problem · 0

THE MANUFACTURER RECEIVED INFORMATION ALLEGING AN ISSUE RELATED TO A BIPAP DEVICE'S SOUND ABATEMENT FOAM. THE PATIENT ALLEGED BEING DIAGNOSED WITH BLADDER CANCER WHILE USING THE DEVICE. MEDICAL INTERVENTION WAS NOT SPECIFIED. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1460155 BIPAP AUTOSV ADV VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING MNS RESPORINOC INC DS960HS 00606959012523

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other